Professor Andrew Pollard, who has led trials of Oxford University and AstraZeneca’s coronavirus vaccine, said they are on track and “optimistic” of securing approval by Christmas. Prof Pollard, who has described work on the vaccine as a “miracle” done at “record speed”, noted that the drug is easier to deliver and ten times cheaper than the vaccine developed by Pfizer and BioNTech.



Comments are closed